AARD vs JBHT · $284.4M cap vs P/E 44, rev $6.55B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus JB Hunt Transport Services Inc (JBHT) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
JB Hunt Transport Services Inc (JBHT) is a integrated freight & logistics company listed on US.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
Latest reported JBHT revenue for 2026-06-30 was $6.55B. Net income was $322.6M. JBHT currently screens at market cap $26.87B and trailing P/E 44.2.
AARD currently screens at market cap $284.4M. JBHT currently screens at market cap $26.87B and trailing P/E 44.2.
Not investment advice. Open the AARD and JBHT stock pages for the full models.
Not investment advice.